Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Quisovalimab by Avalo Therapeutics for Asthma: Likelihood of Approval
Quisovalimab is under clinical development by Avalo Therapeutics and currently in Phase II for Asthma. According to GlobalData, Phase II...
Budesonide by Aquilon Pharmaceuticals for Asthma: Likelihood of Approval
Budesonide is under clinical development by Aquilon Pharmaceuticals and currently in Phase II for Asthma. According to GlobalData, Phase II...
AZD-8630 by AstraZeneca for Asthma: Likelihood of Approval
AZD-8630 is under clinical development by AstraZeneca and currently in Phase I for Asthma. According to GlobalData, Phase I drugs...